Uncategorized

Tirzepatide vs. Semaglutide: Which Is Better for Weight Loss?

Tirzepatide vs. semaglutide: how the two weight-loss medicines compare

Both are weekly GLP-1 medicines approved for type 2 diabetes and weight management, but tirzepatide acts on one extra hormone, and in a head-to-head trial it led to more weight loss.

If you’ve been reading about weight-loss medicines, you’ve likely seen the same two names again and again: semaglutide (sold as Ozempic, Wegovy and Rybelsus) and tirzepatide (sold as Mounjaro and Zepbound).

They’re often talked about as if they’re the same thing. They’re not. So what’s the difference, and is one better than the other?

Here’s how each one works, what the research shows and what to think about if you’re weighing them up.

This page is for general education and isn’t medical advice. Approved semaglutide and tirzepatide medicines need a prescription. Products sold on this website are for lawful research use only.

Medical note: This page is educational and is not medical advice. Approved tirzepatide and semaglutide medicines are prescription-only. Products sold on this website are for lawful research use only.

Tirzepatide vs. Semaglutide: Key Differences

Tirzepatide and semaglutide do a lot of the same things. They lower blood sugar, slow digestion and help you feel full sooner. But they differ in how many hormones they copy and how they’re taken.

In the US, the FDA has approved semaglutide for:

  • Type 2 diabetes (Ozempic, a weekly injection, and Rybelsus, a daily tablet)
  • Chronic weight management in adults and children 12 and older (Wegovy)
  • Lowering the risk of heart attack and stroke in adults with heart disease and overweight or obesity (Wegovy)

And it has approved tirzepatide for:

  • Type 2 diabetes, and lowering the risk of heart attack and stroke in adults with type 2 diabetes at high risk (Mounjaro)
  • Chronic weight management (Zepbound)
  • Moderate to severe obstructive sleep apnea in adults with obesity (Zepbound)

Both tirzepatide and semaglutide are made in a lab. In our shop, they’re listed under the codes GLP-2 TRZ (tirzepatide) and GLP-1 SMA (semaglutide), but this guide uses their real names.

How Semaglutide Works?

Semaglutide copies one hormone, called glucagon-like peptide-1 (GLP-1). That’s why it’s known as a GLP-1 receptor agonist. It can:

  • Help your pancreas release insulin when your blood sugar is high
  • Lower glucagon, a hormone that raises blood sugar
  • Slow how fast food leaves your stomach
  • Make you feel full sooner and for longer
  • Quiet hunger signals in your brain

Natural GLP-1 only lasts a minute or two in your body. Semaglutide was changed so it lasts about a week, which is why the injection is taken once a week. You can read more about how semaglutide works in your body.

How Tirzepatide Works?

Tirzepatide copies GLP-1 too. But it also copies a second hormone, called glucose-dependent insulinotropic polypeptide (GIP). That makes it a dual agonist, sometimes called a “twincretin.” It can:

  • Help your pancreas release insulin when your blood sugar is high
  • Lower glucagon
  • Slow how fast food leaves your stomach
  • Make you feel full sooner and for longer
  • Quiet hunger signals in your brain
  • Add a second, GIP-based boost to the insulin response and appetite control

Researchers are still working out exactly why adding GIP makes such a difference. Despite the shop code, tirzepatide isn’t a GLP-2 medicine (GLP-2 is a different gut hormone). Learn more about how tirzepatide works.

Tirzepatide vs. Semaglutide for Weight Loss

Both medicines can lead to a lot of weight loss. But when they’ve been tested side by side, tirzepatide has come out ahead.

The clearest answer comes from a trial called SURMOUNT-5, published in the New England Journal of Medicine in 2025. It followed 751 adults with obesity who didn’t have diabetes. Each person took the highest weekly dose they could tolerate of either tirzepatide or semaglutide for 72 weeks, along with advice on diet and exercise.

After 72 weeks:

  • People taking tirzepatide lost an average of 20.2% of their body weight
  • People taking semaglutide lost an average of 13.7%
  • About 1 in 3 people on tirzepatide lost a quarter or more of their body weight, compared with about 1 in 6 on semaglutide
  • Waist size went down by about 18 cm on tirzepatide and 13 cm on semaglutide

That’s a real gap. But it’s worth knowing that the trial was funded by Eli Lilly, the company that makes tirzepatide, and that people knew which medicine they were taking.

Tirzepatide vs. Semaglutide for Type 2 Diabetes

If you’re managing type 2 diabetes, there’s head-to-head data here too. A 2021 trial called SURPASS-2 compared three doses of tirzepatide with semaglutide in 1,879 adults who were already taking metformin.

Over 40 weeks, all three tirzepatide doses lowered HbA1c (your average blood sugar over the past few months) more than semaglutide did. People on tirzepatide also lost more weight: up to 11.2 kg, compared with 5.7 kg on semaglutide.

There’s a catch, though. The trial used semaglutide 1 mg, the usual diabetes dose at the time. That’s lower than the 2.4 mg dose used for weight management, so it doesn’t show what semaglutide can do at its highest dose.

Tirzepatide vs. Semaglutide for Heart and Kidney Health

Weight and blood sugar aren’t the whole story. Both medicines now have proof that they can protect the heart, but the evidence comes from different kinds of trials.

In a large trial called SELECT, semaglutide lowered the risk of heart attack, stroke or death from heart disease by 20% compared with a placebo. The people in that trial had heart disease and overweight or obesity, but not diabetes.

Tirzepatide now has heart evidence of its own. A trial called SURPASS-CVOT followed more than 13,000 adults with type 2 diabetes and heart disease for about four years. Instead of a placebo, it compared tirzepatide with dulaglutide, an older GLP-1 medicine that’s already known to protect the heart.

Tirzepatide worked at least as well, with about 8% fewer heart attacks, strokes and heart-related deaths. That difference wasn’t big enough to prove it’s better than dulaglutide, but the FDA has since approved Mounjaro to lower the risk of these events in adults with type 2 diabetes who are at high risk.

Semaglutide is also FDA-approved to help slow kidney disease in people with type 2 diabetes. Because the two heart trials were set up differently, their results can’t be lined up directly.

Tirzepatide vs. Semaglutide Side Effects

Because they work in such similar ways, tirzepatide and semaglutide have similar side effects. They’re most common when you first start or when your dose goes up, and they often ease over time.

Common side effects include:

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Stomach pain
  • Heartburn

In SURMOUNT-5, stomach and digestive side effects showed up at similar rates with both medicines. Less often, both can cause more serious problems, like pancreatitis or gallbladder issues. And if you also take insulin or a sulfonylurea, both can make low blood sugar (hypoglycemia) more likely.

Who Should Avoid Them?

Both medicines carry a boxed warning, the strongest safety warning the FDA gives a prescription drug, about thyroid C-cell tumors seen in animal studies. That’s why you shouldn’t take either one if you or a family member has had medullary thyroid cancer or a condition called multiple endocrine neoplasia type 2 (MEN 2).

They also aren’t recommended during pregnancy.

What About Retatrutide?

You may have also heard of retatrutide. It goes one step further and copies three hormones: GIP, GLP-1 and glucagon.

It’s still being studied in clinical trials, and it isn’t approved by the FDA or by BPOM in Indonesia. See how it stacks up in retatrutide vs. tirzepatide.

Which is The Right Choice for You?

There’s no single winner for everyone. It depends on what matters most to you.

  • If your main goal is losing as much weight as possible, the research favors tirzepatide.
  • If you have type 2 diabetes, both work well, and tirzepatide lowered blood sugar a little more in head-to-head testing.
  • If you have heart disease, both have proof of protecting your heart: semaglutide in people with or without diabetes, and tirzepatide in people with type 2 diabetes.
  • If you’d rather take a pill than an injection, semaglutide is the only one of the two that comes as a tablet (Rybelsus).

Your health history, other medicines, cost and what’s available where you live all play a part, too. The best next step is a conversation with a doctor. If you have questions in the meantime, you can contact us to discuss your goals.

Tirzepatide and semaglutide in Indonesia and Bali

What you can get depends on where you are. Here’s where things stand locally.

Registration in Indonesia

In Indonesia, BPOM has registered Ozempic and Wegovy (semaglutide) and Mounjaro (tirzepatide), all as prescription medicines. You can check any registered product by its number on the BPOM website. [LINK WHEN LIVE: anchor “semaglutide and tirzepatide in Indonesia” → /semaglutide-tirzepatide-indonesia/]

Semaglutide in Bali

If you’re in Bali and leaning toward semaglutide, it helps to know what’s available on the island before you talk to a doctor. Our guide to semaglutide in Bali walks you through local prices and delivery options.

Tirzepatide in Bali

Tirzepatide only recently became available in Indonesia, so it’s worth checking what you can get locally. You’ll find prices and delivery details in our guide to tirzepatide in Bali.

Final Thoughts

Neither medicine is a quick fix. Both work only while you’re taking them.

When people stop, their appetite tends to come back, and much of the weight often returns. In one study, people who stopped semaglutide regained about two-thirds of the weight they’d lost within a year.

That’s why healthy eating, enough protein, regular movement and good sleep still matter, whichever medicine you and your doctor choose.

Frequently Asked Questions

Is tirzepatide better than semaglutide for weight loss?

In the head-to-head SURMOUNT-5 trial, yes. Adults with obesity lost an average of 20.2% of their body weight on tirzepatide and 13.7% on semaglutide after 72 weeks. About twice as many people on tirzepatide lost a quarter or more of their weight.

Why does tirzepatide cause more weight loss than semaglutide?

Tirzepatide copies two gut hormones, GIP and GLP-1, while semaglutide copies only GLP-1. The extra GIP action seems to boost appetite control and the insulin response, but researchers haven’t fully worked out why the combination works better.

Which is better for type 2 diabetes, tirzepatide or semaglutide?

In the SURPASS-2 trial, tirzepatide lowered HbA1c more than semaglutide 1 mg and led to more weight loss. Both are also FDA-approved to lower heart risk in adults with type 2 diabetes, and semaglutide is approved to help slow kidney disease too, so the best choice depends on your health history.

Do tirzepatide and semaglutide have the same side effects?

Mostly, yes. Both commonly cause nausea, diarrhea, vomiting and constipation, especially when you start or raise your dose. In SURMOUNT-5, digestive side effects showed up at similar rates with both. Both also carry the same boxed warning about thyroid tumors.

Does semaglutide or tirzepatide protect the heart?

Both do. In the SELECT trial, semaglutide lowered the risk of heart attack, stroke or death from heart disease by 20% compared with a placebo in adults with heart disease and overweight or obesity. Tirzepatide protected the heart at least as well as dulaglutide, an older heart-protective GLP-1 medicine, in adults with type 2 diabetes, and it’s FDA-approved to lower heart risk in that group.

Can you take tirzepatide and semaglutide together?

No. They both act on the GLP-1 receptor, they aren’t meant to be combined and they haven’t been tested together. If you’re thinking about switching from one to the other, your doctor should plan the change.

Is tirzepatide the same as semaglutide?

No. They’re different medicines from different companies. Tirzepatide (made by Eli Lilly and sold as Mounjaro and Zepbound) copies two hormones, GIP and GLP-1. Semaglutide (made by Novo Nordisk and sold as Ozempic, Wegovy and Rybelsus) copies only GLP-1.

Leave a Reply

Your email address will not be published. Required fields are marked *